Five things to watch in markets in the week ahead
LONDON - UBS Investment Bank announced Thursday it may act as stabilizing manager for Viridium Group S.à r.l.’s upcoming issuance of euro-denominated subordinated notes with a scheduled maturity in 2035.
The stabilization period is expected to begin October 9, 2025, and end no later than November 14, 2025, according to a press release statement. UBS AG London Branch will serve as the stabilizing manager for the offering.
As part of the stabilization activities, UBS may over-allot securities by up to 5% of the aggregate nominal amount or conduct transactions to support the market price of the securities at a level higher than might otherwise prevail.
The total aggregate nominal amount of the subordinated notes has not yet been determined. Other details including the offer price and additional offer terms remain to be confirmed.
The 10.1-year tier 2 notes represent a subordinated debt offering from Luxembourg-based Viridium Group.
The announcement specified that the securities have not been registered under the United States Securities Act of 1933 and may not be offered or sold in the United States without registration or an exemption. The offering is directed at qualified investors in European Economic Area Member States and at persons outside the United Kingdom or those within the UK who have professional investment experience or high net worth status.
UBS noted that while stabilization activities may occur, there is no assurance that any such action will be taken, and any stabilization action may be discontinued at any time.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.